Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
Status:
Withdrawn
Trial end date:
2017-10-26
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies the correlation between the genetics and brain images of
patients with newly diagnosed glioblastoma before surgery. The genetic characteristics of a
tumor are an important way to predict how well it will respond to treatment. Imaging, using
magnetic resonance imaging (MRI), takes detailed pictures of organs inside the body, and may
also provide information that helps doctors predict how brain tumors will respond to
treatment. If MRI can provide doctors with similar information about the tumor as the tumor's
genes, it may be able to be used to predict tumor response in patients whose tumors cannot be
reached by surgery or biopsy to get tissue samples.